• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

West Pharmaceutical Services

How human factors created a new generation of drug delivery devices

November 26, 2019 By Danielle Kirsh

West Pharmaceutical Services SmartDose

Human factor testing is beneficial early on in the design process, rather than as a confirmation at the end. Here’s how testing for usability and desirability helped spark three generations of drug delivery devices. West Pharmaceutical Services has multiple generations of its SmartDose products under its belt since it started working on the drug delivery […]

Filed Under: Drug-Device Combinations, Featured, Research & Development Tagged With: Medical Device Handbook, West Pharmaceutical Services

West Pharmaceutical Services launches two elastomer products

November 6, 2019 By Danielle Kirsh

West Pharmaceutical Services - updated logo

West Pharmaceutical Services (NYSE:WST) yesterday said it launched two new elastomer products, the 4040/40 formulation elastomer and an extension of its AccelTRA component program. The 4040/40 formulation was created using customer insights to improve performance and reliability. It comes in two stopper designs in 13mm and 20mm sizes with a universal design to deliver high functionality […]

Filed Under: Drug-Device Combinations, Materials Testing Tagged With: West Pharmaceutical Services

West Pharmaceutical Services launches NovaPure drug-delivery system

October 22, 2019 By Sean Whooley

West Pharmaceutical Services - updated logo

West Pharmaceutical Services (NYSE:WST) said today that it’s launching the NovaPure 3mL cartridge components with its NovaPure product line for delivery of higher-volume injectable drug-delivery systems. The Exton, Pa.-based company also announced that its SmartDose Gen. II 10mL injector for subcutaneous drug delivery is available for commercialization as well. West’s NovaPure portfolio currently includes stoppers and […]

Filed Under: Drug-Device Combinations, Featured Tagged With: West Pharmaceutical Services

7 MD&M East exhibitors you need to know

June 7, 2019 By Chris Newmarker

MD&M East

MD&M East is one of the largest medical device manufacturing events on the East Coast. Its organizer Informa Markets expects more than 8,000 advanced manufacturing professionals at this year’s event – June 11–13 in New York City. A show such as MD&M East allows officials from medtech companies large and small to network with the constellation […]

Filed Under: Contract Services, Drug-Device Combinations, Featured, Wound Care Tagged With: Freudenberg Medical, Freudenberg Performance Materials, MD&M East, Phillips-Medisize, West Pharmaceutical Services

West Pharmaceutical Services expands Asia Pacific region operations

April 9, 2019 By Danielle Kirsh

West Pharmaceutical Services - updated logo

West Pharmaceutical Services (Exton, Penn.) announced that it has expanded its presence in the Asia Pacific region by opening a new sales office in Korea. The new office is part of West’s recent purchase of the distribution business of GIS Korea, which was previously West’s distributor in the Asia Pacific region. “We are excited to […]

Filed Under: Pharmaceuticals Tagged With: West Pharmaceutical Services

West Pharma’s SmartDose will deliver scPharmaceuticals’ edema drug

February 12, 2019 By Nancy Crotti

scPharmaceuticals

scPharmaceuticals’ (NSDQ:SCPH) has signed a development agreement to incorporate West Pharmaceutical Services’ (NYSE:WST) SmartDose drug delivery system with Furoscix, a drug that scPharmaceuticals developed to treat edema in heart failure patients. Burlington, Mass.-based scPharmaceuticals recently completed preliminary feasibility studies of the drug-device combination. The testing included drug stability in the pre-filled cartridge, drug compatibility, and […]

Filed Under: Business/Financial News, Cardiovascular, Drug-Device Combinations, Uncategorized Tagged With: scPharmaceuticals, West Pharmaceutical Services

FDA: West Pharma recall of Vial2Bag fluid transfer systems is Class I

February 4, 2019 By Fink Densford

West Pharmaceutical Services - updated logo

The FDA recently labeled a select recall of West Pharmaceutical Services‘ (NYSE:WST) Vial2Bag fluid transfer systems over device functionality issues as Class I. Class I designations, the FDA’s most severe, are used when there is a reasonable probability that product use could cause serious adverse health consequences of death. The West Whiteland Township, Penn.-based company’s Vial2Bag […]

Filed Under: Featured, Food & Drug Administration (FDA), Recalls Tagged With: West Pharmaceutical Services

What’s ahead for the drug delivery market in 2019?

January 15, 2019 By Sarah Faulkner

West Pharmaceutical Services - updated logo

Cindy Reiss-Clark, VP & GM of West‘s (NYSE:WST) global biologics business, comments on the drug delivery trends that stood out from 2018 and what she’s keeping an eye on in the coming year.  What were the trends that drove the biopharma and drug delivery markets in 2018? Many of 2018’s key trends revolved around increasing […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: West Pharmaceutical Services

West Pharmaceutical boosts its analytical services with new technology

May 17, 2018 By Sarah Faulkner

West Pharmaceutical

West Pharmaceutical Services (NYSE:WST) has expanded its analytical services capabilities with new equipment to help address the pharmaceutical industry’s packaging and drug-delivery concerns, the company said today. West specifically highlighted its addition of an ion mobility quadrupole time-of-flight mass spectrometer – an instrument that combines chromatography, ion mobility and mass spectrometry. The company also added a […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: West Pharmaceutical Services

Anika CEO retires after two decades; president assumes corner office | Personnel Moves – March 13, 2018

March 13, 2018 By Sarah Faulkner

Anika Therapeutics

Anika Therapeutics (NSDQ:ANIK) announced this month that CEO Charles Sherwood plans to retire after working for Anika for nearly twenty years. Joseph Darling, who has been Anika’s president since July 2017, will take his place in the corner office. Darling has previously served in executive leadership roles across an array of medtech companies like Abbott (NYSE:ABT), Baxter (NYSE:BAX) […]

Filed Under: Drug-Device Combinations, Featured, Personnel, Pharmaceuticals, Wall Street Beat Tagged With: abbott, alucentmedical, Anika Therapeutics Inc., Baxter, BioTime, Brainstorm Cell Therapeutics, Kala Pharmaceuticals, medherant, milestonescientific, pertinaxpharma, smith&nephew, West Pharmaceutical Services

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS